Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2010-02-28
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
NCT00449787
Migraine Treatment in ED
NCT02643719
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
NCT00442221
Migraine Study in Adolescent Patients
NCT00843024
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
NCT03185143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comprehensive care
Reinforcement of diagnosis, education, medications, and referral
Naproxen
Naproxen 500mg PO bid prn headache
Sumatriptan
100mg po q day prn headache
Migraine education
Educational program available through NIH/ national library of medicine/ X-plain
Reenforcement of diagnosis
Patient advised has migraine headache and how the headache meets migraine criteria
Typical care
Usual care
Typical care
Care to be determined by attending physician
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Naproxen
Naproxen 500mg PO bid prn headache
Sumatriptan
100mg po q day prn headache
Migraine education
Educational program available through NIH/ national library of medicine/ X-plain
Reenforcement of diagnosis
Patient advised has migraine headache and how the headache meets migraine criteria
Typical care
Care to be determined by attending physician
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Baseline migraine related disability of mild or worse,
* No current or past triptan use,
* Not satisfied with current headache care.
Exclusion Criteria
* Daily or near daily analgesic medication use.
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin W. Friedman, MD
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-08-248
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.